Sbir phase I topic 410 - cancer clinical trials recruitment and retention tools for participant engagement.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91020C00016
- Awardee
-
Massive Bio, Inc. UEI YJVRMJTJHCG8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $399,594
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Solicitation · PHS20201 · Posted Jun 21, 2019
- Contract value 100% obligated
- $399,594.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 15 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10006, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $399,594 |
About this award
This definitive contract was awarded by the National Institutes of Health National Cancer Institute to Massive Bio, Inc. for $399,594. The contract is associated with the National Institutes of Health and Centers for Disease Control and Prevention SBIR Phase I solicitation seeking proposals for research and development in support of cancer-related topics including clinical trials recruitment and retention tools for participant engagement. The contract will be performed in New York, New York from September 2020 through September 2021 under a firm fixed price structure. This total small business set-aside award furthers the National Cancer Institute's mission by developing tools to help engage participants in cancer clinical trials.
Quick answers
Who was awarded contract 75N91020C00016?
75N91020C00016 was awarded to Massive Bio, Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2020.
How much is contract 75N91020C00016 worth?
The government has obligated $399,594 on 75N91020C00016.
Was contract 75N91020C00016 competed?
The extent of competition for 75N91020C00016 was full and open competition after exclusion of sources. The government received 15 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award